Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
This analysis of the gut microbiome of patients with gastrointestinal cancer receiving anti–PD-1/PD-L1 shows that responders and nonresponders exhibit differential microbial genera. This suggests that the composition of the microbiome could serve as a biomarker of response (Peng et al. 2020a)…